Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle.
暂无分享,去创建一个
[1] W. C. O'Neill,et al. Treatment with pyrophosphate inhibits uremic vascular calcification. , 2011, Kidney international.
[2] A. Rosenthal,et al. Parallel regulation of extracellular ATP and inorganic pyrophosphate: Roles of growth factors, transduction modulators, and ANK , 2011, Connective tissue research.
[3] P. Ciancaglini,et al. Proteoliposomes Harboring Alkaline Phosphatase and Nucleotide Pyrophosphatase as Matrix Vesicle Biomimetics , 2010, The Journal of Biological Chemistry.
[4] P. Ciancaglini,et al. Kinetic Analysis of Substrate Utilization by Native and TNAP-, NPP1-, or PHOSPHO1-Deficient Matrix Vesicles , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] W. C. O'Neill,et al. Plasma pyrophosphate and vascular calcification in chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] Brock T Brown,et al. Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). , 2009, Journal of medicinal chemistry.
[7] X. Chan,et al. Identification and Characterization of Novel Tissue-Nonspecific Alkaline Phosphatase Inhibitors with Diverse Modes of Action , 2009, Journal of biomolecular screening.
[8] G. Dubyak,et al. Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. , 2009, American journal of physiology. Cell physiology.
[9] J. Millán,et al. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. , 2008, Kidney international.
[10] G. Yegutkin. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. , 2008, Biochimica et biophysica acta.
[11] J. Millán,et al. Novel Inhibitors of Alkaline Phosphatase Suppress Vascular Smooth Muscle Cell Calcification , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[12] J. Sévigny,et al. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.
[13] D. Kingsley,et al. Biochemical and genetic analysis of ANK in arthritis and bone disease. , 2006, American journal of human genetics.
[14] M. Bollen,et al. Modulation of purinergic signaling by NPP-type ectophosphodiesterases , 2006, Purinergic Signalling.
[15] M. McKee,et al. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. , 2005, Genes & development.
[16] R. Terkeltaub,et al. Chondrogenesis Mediated by PPi Depletion Promotes Spontaneous Aortic Calcification in NPP1−/− Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[17] G. Dubyak,et al. Methylene ATP analogs as modulators of extracellular ATP metabolism and accumulation , 2004, British journal of pharmacology.
[18] W. C. O'Neill,et al. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. , 2004, Journal of the American Society of Nephrology : JASN.
[19] P. Schauerte,et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. , 2001, The American journal of pathology.
[20] D. Kingsley,et al. Role of the mouse ank gene in control of tissue calcification and arthritis. , 2000, Science.
[21] J. Meyer,et al. Can biological calcification occur in the presence of pyrophosphate? , 1984, Archives of biochemistry and biophysics.
[22] H. Fleisch,et al. Inhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats. , 1968, Clinical science.